Loci Affecting Colon Cancer Susceptibility

描述（由申请人提供）：结肠癌是最常见的人类恶性肿瘤之一，在美国每年有15万新病例和6万死亡病例。一些参与结肠肿瘤发展的分子变化是已知的，在大约20%的病例中，结肠肿瘤易感性的遗传基础已经被确定，要么是Apc基因座的突变，要么是编码DNA合成/修复蛋白质的基因座的突变。对零星谣言易感性的遗传基础（约80%的病例）是未知的，可能是复杂的。我们一直在用小鼠模型研究致癌物诱导的结肠癌的易感性，首先使用致癌物1,2-二甲肼二盐酸盐（DMH），然后使用其代谢物偶氮甲烷（AOM），后者更稳定，需要更少的注射。菌株ICR/Ha对dmh诱导的结肠肿瘤高度敏感，而菌株C57BL/6Ha对dmh诱导的结肠肿瘤具有耐药性。将（ICRxC57BL/6） F1回交至C57BL/6Ha，用DMH处理122个子代。在其中一些后代中检测到结肠肿瘤，并根据所有染色体上的遗传位点进行分型。利用每只动物的肿瘤数量进行QTL分析表明，在Chrs 5、12、13和14上的4个染色体区域含有影响致癌物诱导的结肠肿瘤数量的等位基因差异基因。构建了一组同源菌株，在抗性菌株的背景下，分别将敏感等位基因置于四个染色体区域的每个区域。这些菌株的N5F2代的动物用DMH处理，在所有四个基因系的大多数动物中发现结肠肿瘤。所有染色体都产生了亚同源系，其中两组（Chrs 12和14）对AOM敏感。我们现在提出四个具体目标。在第一个目标中，我们计划通过减少基因区域的长度来进一步完善每个基因的定位。在第二个目标中，我们计划完善我们使用AOM的方案，以确定最佳的注射时间表，以便所有ICR/Ha小鼠都产生肿瘤。在此之后，将对来自亚同源菌株的动物进行测试，以确定包含决定敏感性基因的最小亚同源间隔。在第三个目标中，我们将解决肿瘤本身发生什么遗传变化的问题，以及是否存在特异性，使任何一种同源菌株引起的肿瘤显示出一致的变化概况。

DESCRIPTION (provided by applicant): Colon cancer is one of the most frequent human malignancies, with 150,000 new cases and 60,000 deaths per year in the United States. Some of the molecular changes involved in the development of colon tumors are known, and in about 20% of the cases the genetic basis for colon tumor susceptibility has been identified, either as a mutation in the Apc locus or as a mutation in a locus encoding a protein involved in DNA synthesis/repair. The genetic basis for susceptibility to sporadic rumors, about 80% of cases, is unknown and is probably complex. We have been working with a mouse model for susceptibility to carcinogen-induced colon cancer, first using the carcinogen 1,2-dimethylhydrazine dihydrochloride (DMH) and later its metabolite azoxymethane, (AOM), which is more stable and requires fewer injections. Strain ICR/Ha is highly sensitive to DMH-induced colon tumors, while strain C57BL/6Ha is resistant. The (ICRxC57BL/6) F1 hybrid was backcrossed to C57BL/6Ha, and 122 progeny were treated with DMH. Colon tumors were detected in some of these progeny, which were typed for genetic loci on all chromosomes. QTL analysis using the number of tumors per animal suggested that four chromosomal regions, on Chrs 5, 12, 13 and 14, contained genes with allelic differences that affected the number of carcinogen-induced colon tumors. A set of congenic strains have been constructed that separately place the sensitive alleles at each of the four chromosomal regions on the background of the resistant strain. Animals from generation N5F2 of each of these strains were treated with DMH and colon tumors were found in most animals from all four congenic lines. Subcongenic lines have been generated for all chromosomes and two sets (Chrs 12 and 14) have been tested and are sensitive to AOM. We now propose four Specific Aims. In the first aim we plan to further refine the mapping of each gene by decreasing the length of the congenic region. In the second aim we plan to refine our protocol for use of AOM to determine the best injection schedule so that all ICR/Ha mice develop tumors. Following this, animals from the subcongenic strains will be tested to identify the smallest subcongenic interval containing the gene determining sensitivity. In the third aim we will address the question of what genetic changes occur in the tumors themselves, and whether there is specificity such that tumors arising from any one of the congenic strains show a consistent profile of changes.